X4 Pharmaceuticals, Inc. buy Stifel Nicolaus
Start price
14.11.24
/
50%
€0.34
Target price
14.11.25
€3.80
Performance (%)
-50.47%
End price
15.11.25
-
Summary
This prediction is currently being closed. The BUY prediction by Stifel_Nicolaus for X4 Pharmaceuticals, Inc. is performing very badly with a performance of -50.47%. Stifel_Nicolaus has a follow-up prediction for X4 Pharmaceuticals, Inc. where he still thinks X4 Pharmaceuticals, Inc. is a Buy. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| X4 Pharmaceuticals, Inc. | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Stifel_Nicolaus for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its price target lowered by analysts at Stifel Nicolaus from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for XFOR provided by MarketBeat
In the thread Trading X4 Pharmaceuticals, Inc.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Current prediction by Stifel_Nicolaus for X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€0.17
29.08.25
29.08.25
€7.72
29.08.26
29.08.26
-
25.04.25
25.04.25
